五种腹腔镜抗反流术式一年结局的真实世界比较
该单中心回顾性队列纳入359例胃食管反流病患者,比较Nissen、Toupet、Dor、His角重建与W-H胃底折叠五种腹腔镜术式术后1年效果。五种术式均持续改善症状与生活质量,早期吞咽困难以Nissen最明显但6至12个月趋于一致,1年时患者报告结局无临床意义的组间差异。
要点
- 五种腹腔镜抗反流术式术后1年均持续改善症状与生活质量。
- 早期吞咽困难以Nissen最明显,但6至12个月趋于一致。
- 术前症状严重程度是症状复发的唯一独立预测因素。
核心结论
- 五种腹腔镜抗反流术式均与术后1年患者报告症状和生活质量的大幅改善相关。
- 术后早期吞咽困难因术式而异但多随时间缓解,中期结局更多取决于基线症状负担和基于表型的术式选择。
研究设计与样本
- 单中心回顾性队列,2016年1月至2024年5月,359例GERD患者接受五种腹腔镜抗反流术式之一。
- 纵向评估总症状评分、SF-36 PCS/MCS、GERD-HRQL和EAT-10,采用线性混合效应模型分析纵向轨迹。
- 采用多变量Firth logistic回归识别1年症状复发和持续PPI依赖的预测因素。
主要发现
- 五种术式均与1年内症状持续改善及生理和心理生活质量显著获益相关。
- 术后早期吞咽困难因术式而异,以Nissen最明显,但6至12个月趋于一致,1年时各组EAT-10评分接近正常。
- 1年时患者报告结局未观察到有临床意义的组间差异。
- 术前症状严重程度是症状复发的唯一独立预测因素(每增加1分OR=1.13;P<0.001)。
- 校正后手术类型与症状复发或PPI依赖无关。
临床怎么用
- 术式选择可基于患者表型和基线症状负担个体化决策,而非追求单一通用金标准术式。
- 术前症状严重程度较高者术后症状复发风险更高,应加强随访和患者沟通。
- Nissen术后早期吞咽困难较明显,但多在6至12个月内缓解,可据此进行围术期宣教。
局限性
- 单中心回顾性队列设计,可能存在选择偏倚和混杂。
- 随访时间仅1年,缺乏更长期结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Gastroesophageal reflux disease (GERD) is a global health burden, and the optimal choice among various laparoscopic antireflux procedures remains debated. We compared the effectiveness of five surgical techniques-Nissen, Toupet, Dor, His angle reconstruction, and W-H fundoplication-over a 1-year postoperative period. MATERIALS: In this single-center retrospective cohort (January 2016-May 2024), 359 GERD patients underwent one of the five laparoscopic procedures. Total symptom score, SF-36 PCS/MCS, GERD-HRQL, and EAT-10 were assessed longitudinally. Longitudinal trajectories were analyzed using linear mixed-effects models with estimated marginal means. Multivariable (Firth) logistic regression was used to identify the predictors of 1-year symptom recurrence and persistent PPI dependence. RESULTS: All five procedures were associated with sustained symptom improvement and significant gains in physical and mental quality of life over 1 year. Early postoperative dysphagia differed among procedures-most pronounced after Nissen-but converged by 6 to 12 months, with near-normal EAT-10 scores across groups at 1 year. No clinically meaningful between-procedure differences were observed in patient-reported outcomes at 1 year. Preoperative symptom severity was the only independent predictor of symptom recurrence (OR = 1.13 per point increase; P < 0.001), whereas surgical type was not associated with symptom recurrence or PPI dependence after adjustment. CONCLUSIONS: These five laparoscopic antireflux procedures were associated with substantial improvement in patient-reported symptoms and quality of life at 1 year. Early postoperative dysphagia differed among procedures but largely resolved over time. Mid-term outcomes appear to depend more on baseline symptom burden and phenotype-informed procedure selection than on adherence to a single universal "gold standard" technique.
引用
- Chai Y, Zhang P, Lyu P, et al. Comparing Nissen, Toupet, Dor, His reconstruction, and W-H fundoplication: real-world 1-year outcomes of five laparoscopic antireflux procedures. Surg Endosc. 2026. PMID: 42115372. doi:10.1007/s00464-026-12813-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。